The γ-H2AX foci, induced by 177Lu-DOTATOC, have been reported as predictors of response to treatment in SSTR-expressing neuroendocrine tumor cells in both in vitro and in vivo models [134,135]. The gene discussed is H2AX; the disease is neuroendocrine neoplasm.